Engineered components manufacturer for critical industries ITT Inc. (NYSE: ITT) reported Q3 CY2025 results , with sales up 12 ...

With a 6% Monday-to-Thursday increase in its stock price, according to data compiled by S&P Global Market Intelligence, ITT ...

ITT (NYSE: ITT) has outperformed the market over the past 15 years by 9.3% on an annualized basis producing an average annual return of 21.5%. Currently, ITT has a market capitalization of $15.25 ...

ITT has done a great job refining its portfolio through various spinoffs over the last few decades. Its current portfolio of automotive, locomotive, aerospace, and industrial plant components are ...

Discover ITT Inc.'s impressive Q3 2025 growth, raised EPS guidance, and strong outlook driven by innovation and M&A.

Welcome to ITT's 2025 Third Quarter Conference Call. Today is Wednesday, October 29, 2025. Today's call is being recorded and will be available for replay beginning at 12 p.m. Eastern Time. [Operator ...

The company raised the EPS outlook for 2025 to a range of $6.16 to $6.22, up from $5.95 to $6.15. It also raised its full-year adjusted earnings outlook to $6.62 to $6.68 a share, up from its previous ...

STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — ITT Corp. (ITT) on Wednesday reported third-quarter earnings of $126.9 million. The Stamford, Connecticut-based company said it had net income of $1.62 ...

The Trump administration is proud to bequeath to the University this list of courses bound to get you in accordance with the ...

The Health of Mother Earth Foundation (HOMEF) has commenced a campaign to halt oil extractions and ensure conservation and ...

ATLANTA -- Oral tebipenem pivoxil (TBP-PI) was non-inferior to IV imipenem-cilastatin (IMI-CIL) for treating complicated ...

These data support the use of pembrolizumab plus weekly paclitaxel, with or without bevacizumab, as a new standard of care for patients with platinum-resistant, recurrent ovarian cancer,” said ...